◆ 會議時間：2026年10月23-27日
◆ 會議地點：西班牙 馬德里
◆ 會議簡介：
2026年歐洲腫瘤內科學會(ESMO)年會/大會將于2026年10月23-27日在西班牙馬德里舉行，會議由歐洲腫瘤內科學會(ESMO)主辦。歐洲腫瘤內科學會年會(ESMO大會)是歐洲最負盛名和最具影響力的腫瘤學會議，每年都有超過30,000名專業人士參加會議；屆時來自世界各地的臨床醫生、研究人員、患者倡導者、記者和制藥業人士將齊聚一堂，一起分享了解腫瘤學領域的最新進展，并將科學轉化為最佳的癌癥患者護理。ESMO大會科學計劃將由一個300多名國際專家組成的委員會制定，內容涵蓋從基礎研究到癌癥免疫治療的最新發現，從腫瘤護理到姑息治療，從罕見癌癥到藥物批準，等等。ESMO年度大會將成為轉化研究、呈現實踐變化數據宣和多學科討論的卓越全球平臺，大會將提供優秀的科學教育計劃，為代表們提供了豐富的交流意見的機會。（2025ESMO年會數字：37000余名與會者來自170多個國家/地區；600余位演講嘉賓；2900多份摘要展示）
歐洲腫瘤內科學會（ESMO）成立于1975年，是全球領先的腫瘤內科學專業組織。ESMO是腫瘤學教育和信息的參考學會，現在全球160多個國家和地區擁有超過25,000余名會員；ESMO致力于通過宣促進多學科的癌癥護理，支持腫瘤學家的專業發展以及在全球倡導可持續的癌癥護理，盡而為癌癥患者提供最佳的護理。未經本站許可，禁止復制轉載摘錄鏡像本站任何內容-領域國際醫學會議網(lingyuint.com)。
ESMO 2026 - European Society of Medical Oncology (ESMO) Congress 2026
Date:
23-27 October 2026
Venue:
IFEMA MADRID (Madrid, Spain)
The ESMO Congress is a highly influential global oncology meeting for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.?
ESMO 2026 will be a platform for breakthroughs in oncology research, clinical practice and patient care.
Participants can expect impactful new data, interactive education, excellent networking opportunities and an innovative exhibition area. By attending the ESMO Congress 2026, oncologists will not only gain insights into the latest developments but also play an active role in shaping the future of oncology on a global scale.
Save the date for ESMO 2026, taking place in Madrid, Spain, on 23-27 October 2026.
摘要征文投稿：
Abstract submission deadlines-征稿截止日期
The abstract submission system will open in February 2026
Abstract submission deadlines
| Deadline |
Date and time |
- Abstracts
- Trials in Progress
- Intent to submit LBAs
|
12 May 2026, 21:00 CEST?
|
|
8 September 2026, 21:00 CEST
A skeleton indicating the type of data that will be available by the late-breaking abstract deadline?must be submitted online?by the regular abstract deadline on?12?May 2026. |
Abstract submission categories
- AI for diagnostics and profiling (pathology, radiology, molecular biology)
- AI for clinical workflows and decision-making
- AI for clinical research and drug development
- Basic science
- New diagnostic tools
- Pathology and molecular pathology
- Translational research and biomarkers
- Breast cancer, early stage
- Advanced breast cancer, other
- HER2+ breast cancer
- HR+ breast cancer
- Triple negative breast cancer
- CNS tumours
- Developmental therapeutics
- Biliary tract cancer, incl. cholangiocarcinoma
- Hepatocellular carcinoma (HCC)
- Oesophagogastric cancer
- Pancreatic cancer
- Colon cancer
- Rectal and anal cancer
- Germ cell (testicular) cancer and penile cancer
- Localised and locally advanced prostate cancer
- Metastatic prostate cancer
- Renal cancer
- Urothelial cancer
- Gynaecological cancers
- Haematological malignancies
- Head and neck cancer, excluding thyroid
- Investigational immunotherapy
- Melanoma
- Non-melanoma skin tumours
- Endocrine tumours
- Neuroendocrine tumours
- Thyroid cancer
- NSCLC, early stage
- NSCLC, locally advanced
- SCLC
- Thoracic malignancies, other
- NSCLC, metastatic
- Policy
- Sarcoma
- Early detection and intervention
- Primary prevention
- Secondary prevention
- Palliative care
- Psycho-oncology
- Supportive care
- Miscellaneous
- *Cancer Nursing: Digital innovation and technology in practice
- *Cancer Nursing: Equitable health care of underserved population
- *Cancer Nursing: Palliative and advanced cancer care across the cancer continuum
- *Cancer Nursing: Prevention, early detection and health promotion
- *Cancer Nursing: Supportive care and symptom management
- *Cancer Nursing: Workforce development for the future
*Abstracts may also be submitted to the Cancer nursing track. Submissions in these categories will be reviewed by the European Oncology Nursing Society (EONS) Scientific Committee for selection and presentation in the EONS cancer nursing programme. Unless otherwise stated, submissions in the Cancer nursing categories must follow all regular ESMO Congress 2026 submission regulations and guidelines.
Late-breaking abstracts (LBAs)
Late-breaking abstracts may be submitted for high quality, new research findings from prospective interventional clinical trials or observational series (large real world data sets) or novel technologies with major implications for clinical practice and/or understanding and targeting of disease processes.?
The final late-breaking abstract deadline of 8 September 2026 is?under no circumstances?to be considered as an extension of the general submission deadline.
Presentation and publication of accepted abstracts
The ESMO Congress 2026 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:
- Presidential Symposium?– Oral presentations by authors presenting cutting-edge and significant clinical practice-changing studies, followed by expert discussion and perspectives.
- Proffered Paper?– Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
- Rapid Oral?– Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
- Poster?– Paper poster presentation for review and discussion onsite. Presenting authors must attend the Congress in person to represent their work. Preparation of an e-Poster file is also mandatory for inclusion in the Congress Virtual Platform and onsite digital screens.
- E-Poster?– Electronic poster in PDF format for inclusion in the Congress Virtual Platform and onsite digital screens. Presenting authors of ePosters are not required to attend the Congress in person to represent their work. Paper posters are?not to be prepared, and poster boards will not be provided.
All accepted abstracts, will be published online in the ESMO Congress 2026 Abstract Book, a supplement to the official ESMO journal,?Annals of Oncology.
ESMO Merit Award
A restricted number of ESMO Merit Awards for the ESMO Congress 2026 are available, upon application, to first authors (= presenters) who submit abstracts considered to be deserving of recognition.
Candidates must be?ESMO Members under the age of 40?and indicate that they wish to be considered for a Merit Award at the time of submitting the abstract.
The selection will be made by the Scientific Committee on a competitive basis considering the scientific merit of the abstract.
下為上屆信息
ESMO2025 注冊費：
Registration includes:
- Admission to onsite scientific and educational sessions with the possibility to interact with Speakers, Session Chairs and panel speakers
- Networking opportunities with the congress faculty and peers
- Entry to the poster and e-poster area
- Interaction with industry partners in the trade exhibition?
- Participation in the Industry Satellite Symposia
- Access to the virtual congress platform to watch the sessions live or view the content on-demand
- Post-event resources (webcasts, slides, abstracts) on OncologyPRO
Registration fees?
(19% German VAT included) |
Early registration?
until 16 July 2025? |
Late registration?
until 10 September 2025? |
Full registration?
from 11 September 2025? |
ESMO Member |
€ 665.00 |
€ 934.00 |
€ 1,195.00 |
ESMO Member Developing Countries* |
€ 185.00? |
€ 300.00? |
€ 598.00 |
ESMO Member in Training** |
€ 107.00 |
€ 140.00 |
€ 210.00 |
ESMO Member Undergraduate Student |
€ 107.00 |
€ 140.00 |
€ 210.00 |
ESMO / EONS Member Nurse |
€ 555.00 |
€ 555.00 |
€ 555.00 |
ESMO Member Patient Advocate |
€ 107.00 |
€ 140.00 |
€ 210.00 |
EONS Early Career Nurse*** |
€ 107.00 |
€ 107.00 |
€ 107.00 |
Non-Member |
€ 1,040.00? |
€ 1,315.00 |
€ 1,595.00 |
*Applicable to ESMO members from developing countries only. At the time of application, developing countries are defined by ESMO according to the World Bank classification of low, lower-middle and upper-middle countries based on the Gross National Income (GNI) per capita.?Download the PDF?outlining which countries are eligible for the discounted registration fees.
** ESMO Members must be under 40 and in training to qualify for this fee.
***?EONS Cancer Nurses must be under 35 to qualify for this fee.
Other registration fees
(19% German VAT included) |
Fee? |
Access? |
Private Meeting badge |
€ 265.00 |
Exhibition & Satellites, private meeting & business rooms |
Industry Symposium badge |
€ 265.00 |
Exhibition & Satellites, private meeting & business rooms Exhibition & Satellites, private meeting & business rooms |
Exhibitor Visitor badge |
€ 130.00 |
Exhibition area only |
Third Party Media |
€ 700.00 |
Venue common area, filming area, private meeting and business rooms |
Please send an email to?registration@esmo.org?to request one of the badges in the "Other registration fees" table above.
ESMO2025-歐洲腫瘤年會-ESMO歐洲腫瘤內科學會2025-ESMO年會/大會-ESMO Congress 2025
◆ 參會對象：
腫瘤科醫師、放射科醫師，介入放射科醫師，外科/普外科醫師，病理科醫師，護士以及從事腫瘤護理與研究的其他相關專業人士等。
|
